Introduction
Timothy syndrome (TS), also referred to as syndactylyassociated long QT syndrome (LQTS) or LQT8, is a multi-system disorder characterized by developmental defects causing dysmorphic facial features, congenital heart abnormalities, neurocognitive impairment, and webbing of the toes and fingers (syndactyly) (1) . TS is caused by mutations of the CACNA1C gene, which encodes L-type calcium channel Ca (V) 1.2. Two types of TS have been defined according to the mutation sites: G406R in exon 8A (TS1) and G402S/G406R in exon 8 (TS2). These gain-offunction mutations result in an impaired open-state and voltagedependent inactivation of the L-type calcium channel, ultimately leading to a markedly prolonged myocardial action potential (delayed ventricular repolarization) (1) (2) (3) (4) . This paper presents a two-and-a-half-year-old female patient who had cardiac arrest (CA) during an operation for inguinal hernia (IH) and syndactyly upon which short-term resuscitation was performed. The diagnosis of TS was established on the basis of the electrocardiography (ECG)-Holter findings [long QTc (corrected QT) (>600 ms), 2:1 AV block (AVB), and T-wave alternans (TWA)] and typical clinical features, and it was confirmed by molecular genetic analysis (MGA). An epicardial dual-chamber implantable cardioverter defibrillator (EDCICD) was implanted in the patient, and treatment with propranolol was initiated. To the best of our knowledge, this is the first report from Turkey about TS.
Case Report
The female patient at the age of two-and-a-half years was referred to us because of the development of CA and the performance of short-term resuscitation during surgery for IH and syndactyly. According to the physical examination, her weight was 10 kg (<3.p) and height was 80 cm (<3.p). She had physical and neuro-motor development retardation. The patient had a slightly dysmorphic-looking face and syndactyly between the 4 th and 5 th fingers and 2 nd and 3 rd toes (Fig. 1 ). According to her cardiovascular examination, she had bradycardia; her peak heart rate was 45-50/min and blood pressure 105/60 mm Hg. She had a 2/6 systolic murmur over the mesocardiac, and her femoral pulses were bilaterally palpable. All other system examinations were unremarkable was normal, and she had an LQTc interval (QTc: 696 ms) and a 2:1 AVB, and T wave alter- nans (TWA) as confirmed by 12-lead ECG and 24-h Holter ECG monitoring results (Fig. 2a) . Two small mid-muscular ventricular septal defects and a small, patent ductus arteriosus in the echocardiograph were observed. The diagnosis of TS was established on the basis of the ECG and Holter findings and typical clinical features, and it was confirmed by MGA, which showed the typical G406R mutation of exon 8 of the CACNA1C (c.1216G>A) gene. Treatment with a beta-blocker (propranolol, 3 mg/kg/day) was started and EDCICD was implanted in the patient (Fig. 2b) .
Discussion
Most children with TS have potentially fatal arrhythmias including 2:1 AVB, torsade de pointes, and ventricular fibrillation (1, 2, 5, 6) . The number of TS cases reported in literature in English to date is below 35 (4), and our case is the first genetically diagnosed TS case reported in Turkey.
TS is one of the most severe types of LQTS, and its high mortality at a very young age is likely caused by cardiac arrhythmias precipitated by infections, severe illnesses, or anesthesia (1, 4) . In our case, because of CA after anesthesia, LQTS should be considered in such cases. Because ventricular tachyarrhythmia is the leading cause of death in patients with TS, effective antiarrhythmic medications and implantable cardioverter defibrillators (ICDs) are the mainstay of therapy. Because of the small number of patients, no validated drug therapies have been established so far. For other forms of LQTS, beta-blockers are reported to be a treatment option. The calcium channel blockers ranolazine and mexiletine have been used to prevent ventricular tachyarrhythmia (4, 5, 7, 8) . Gao et al. (4) showed that mexiletine shortens QTc, attenuates QT-RR slope, and abolishes 2:1 AVB and TWA in a TS patient and TS model via the inhibition of late I Na channel. TS should be considered in every patient with a confirmed diagnosis as soon as the body weight allows the procedure for primary prophylaxis of sudden cardiac death even in patients without documented ventricular tachycardia (1) (2) (3) (4) (5) . Because the age and weight of our patient were appropriate, an epicardial ICD was implanted in addition to beta-blocker treatment.
Conclusion
The presence of bradycardia, LQT-interval, and 2:1 AVB in combination with multi-systemic signs during the newborn stage and infancy period should suggest TS. Because of the nature and poor progress of the disease, ICD implantation should be performed along with medical treatment for patients at the appropriate age and weight.
